mani
viral
infect
pose
great
danger
human
livestock
often
caus
death
signific
econom
loss
instanc
influenza
spread
around
world
season
epidem
result
approxim
three
five
million
yearli
case
sever
ill
approxim
yearli
death
previou
centuri
deadli
virus
caus
pandem
worldwid
number
occas
moreov
new
reemerg
infecti
viral
diseas
pose
rise
global
health
threat
risk
spread
virus
contin
countri
even
larger
hivaid
sever
acut
respiratori
syndrom
sar
recent
pandem
influenza
mani
exampl
emerg
infecti
diseas
modern
world
number
prevent
therapeut
measur
includ
biosecur
vaccin
antivir
drug
routin
use
prevent
treat
viral
diseas
vaccin
form
basi
prevent
mani
viral
infect
substanti
drawback
influenza
viru
vaccin
failur
wide
document
elderli
popul
mortal
occur
vaccin
approxim
effect
moreov
eventu
pandem
infect
new
strain
antivir
drug
repres
first
line
defens
due
metabol
properti
virus
difficult
control
rel
drug
treatment
viral
diseas
howev
side
effect
associ
central
nervou
system
gastrointestin
tract
well
rapid
emerg
antivir
resist
therapi
limit
use
drug
therefor
innov
strategi
respons
requir
come
across
econom
human
health
risk
associ
viral
diseas
histor
natur
herbal
medicin
use
mani
societi
treatment
human
diseas
approxim
plant
speci
use
medicin
purpos
report
particular
lot
extract
substanc
medic
herb
plant
report
antivir
effect
infecti
virus
therefor
extract
natur
product
pure
compound
standard
plant
extract
provid
unlimit
opportun
new
antivir
drug
high
efficaci
low
toxic
minor
side
effect
epimedium
koreanum
nakai
evergreen
perenni
flower
plant
belong
famili
berberidacea
aerial
part
plant
wide
use
tradit
korean
chines
herbal
medicin
treat
infertil
impot
neurasthenia
cardiovascular
diseas
amnesia
lumbago
arthriti
variou
immunemodulatori
problem
also
aphrodisiac
antirheumat
thousand
year
addit
recent
pharmacolog
studi
demonstr
epimedium
koreanum
nakai
contain
antiinflammatori
hypotens
antioxid
antitumor
activ
importantli
shown
epimedium
koreanum
nakai
enhanc
immun
function
howev
antivir
effect
epimedium
koreanum
nakai
complet
investig
moreov
despit
multipl
biolog
properti
avail
scientif
data
epimedium
koreanum
nakai
immunemodulatori
potenti
respons
molecul
report
studi
evalu
antivir
activ
total
aqueou
extract
epimedium
koreanum
nakai
wide
array
virus
vitro
vivo
addit
confirm
immunemodulatori
potenti
regul
innat
immun
respons
epimedium
koreanum
nakai
addit
tri
identifi
activ
molecul
present
aqueou
fraction
final
prophylact
efficaci
epimedium
koreanum
nakai
diverg
influenza
subtyp
includ
evalu
balbc
murin
infect
model
watersolubl
herbal
extract
epimedium
koreanum
nakai
prepar
herbal
medicin
improv
research
center
korea
institut
orient
medicin
daejeon
republ
korea
medicin
herb
dri
bark
plant
obtain
yeongcheon
orient
herbal
market
yeongcheon
korea
verifi
professor
ki
hwan
bae
colleg
pharmaci
chungnam
nation
univers
detail
g
dri
bark
place
l
distil
water
extract
heat
h
use
medic
heat
plate
gyeongseo
extractor
incheon
korea
extract
epimedium
koreanum
nakai
filter
use
filter
paper
darmstadt
germani
store
h
extract
centrifug
rpm
min
supernat
collect
ph
adjust
total
aqueou
extract
subject
membran
syring
filtrat
darmstadt
germani
lyophil
final
yield
water
extract
epimedium
koreanum
nakai
adjust
mgml
phosphat
buffer
salin
pb
store
administr
atcc
mdck
atcc
vero
atcc
cell
grown
dulbeccocc
cell
grow
dmem
invitrogen
carlsbad
ca
usa
supplement
fetal
bovin
serum
fb
gibco
grand
island
ny
usa
antibioticantimycot
solut
gibco
grand
island
ny
usa
grand
concentr
green
fluoresc
protein
gfp
tag
influenza
newcastl
diseas
viru
ndvgfp
challeng
influenza
virus
propag
allanto
fluid
chicken
embryo
vesicular
stomat
viru
vsvgfp
herp
simplex
viru
hsv
propag
confluent
vero
cell
author
receiv
green
fluoresc
protein
gfp
tag
ndv
vsv
hsv
virus
dr
jae
u
jung
depart
molecular
microbiolog
immunolog
univers
southern
california
usa
cell
grown
plate
cellswel
cellswel
respect
incub
atmospher
hour
medium
replac
twofold
serial
dilut
epimedium
koreanum
nakai
alwel
hour
post
treatment
hpt
cell
wash
pb
infect
use
dmem
contain
fb
cell
infect
moi
vsvgfp
moi
ndvgfp
moi
hsvhfp
moi
cell
infect
vsvgfp
moi
hsvgfp
moi
virus
hour
post
infect
hpi
inocula
remov
wash
pb
replac
dmem
contain
fb
experi
perform
triplic
gfp
express
measur
hpi
glomax
multidetect
system
promega
wi
usa
accord
manufactur
instruct
graph
develop
differ
cell
line
infect
individu
virus
base
dilut
gfp
express
valu
valu
calcul
extract
concentr
yield
gfp
express
evalu
cell
viabil
assay
trypan
blue
exclus
test
describ
elsewher
assay
perform
use
tissu
cultur
plate
increas
concentr
plant
extract
ad
confluent
cell
monolay
h
cell
viabil
determin
trypan
blue
exclus
test
clarifi
cell
treatment
group
mix
trypan
blue
stain
invitrogen
usa
ratio
stain
mixtur
appli
hemocytomet
obtain
percentag
viabl
cell
total
number
viablel
cell
per
ml
aliquot
divid
total
number
cellsml
aliquot
multipli
cell
count
done
thrice
graph
concentr
extract
function
cell
viabil
develop
calcul
concentr
extract
result
cell
viabil
experi
perform
triplic
viral
replic
inhibit
assay
perform
accord
moon
et
al
modif
cell
grown
tissu
cultur
plate
cellswel
incub
h
simultan
cell
cultur
sixwel
tissu
cultur
plate
cellswel
similar
condit
dmem
alon
untreat
virusonli
group
dmem
u
recombin
mousehuman
interferon
ifn
posit
control
sigma
st
loui
missouri
usa
dmem
epimedium
koreanum
nakai
incub
differ
well
pretreat
assay
h
posttreat
hpt
well
gentli
wash
phosphatebuff
salin
pb
infect
cell
infect
either
vsvgfp
moi
moi
ndvgfp
moi
hsvgfp
moi
use
dmem
supplement
fb
addit
cell
infect
vsvgfp
moi
hsvgfp
moi
virus
two
hour
postinfect
hpi
unattach
virus
aspir
supernat
well
gentli
wash
pb
dmem
supplement
fb
antibioticantimycot
solut
ad
well
gfp
express
reflect
viru
replic
observ
h
post
infect
hpi
magnif
viru
titrat
cell
viabil
determin
hpi
cell
viabil
determin
via
trypan
blue
exclus
cell
count
perform
triplic
total
mrna
cell
extract
amplifi
estim
ndvgfp
mrna
express
level
cell
cultur
tissu
cultur
plate
cellswel
incub
h
medium
replac
dmem
alon
untreat
virusonli
group
dmem
epimedium
koreanum
nakai
twelv
hour
posttreat
cell
infect
ndvgfp
moi
harvest
hpi
total
mrna
extract
use
rneasi
mini
kit
qiagen
seoul
korea
convert
cdna
pcr
perform
use
specif
primer
gene
forward
primer
revers
primer
gtccgagcacatcact
gapdh
forward
primer
revers
primer
equal
amount
pcr
product
run
ethidium
bromid
agaros
gel
visual
use
geldoc
imag
system
biorad
seoul
korea
final
rel
band
intens
rbi
matrix
gene
compar
gapdh
determin
use
geldoc
imag
system
band
quantif
softwar
biorad
viral
titer
measur
plaqu
assay
use
vero
cell
briefli
cell
cultur
sixwel
tissu
cultur
plate
cellswel
cellswel
respect
incub
h
medium
replac
dmem
alon
untreat
virusonli
group
dmem
u
recombin
mousehuman
interferon
ifn
mem
alon
epimedium
koreanum
nakai
twelv
hour
posttreat
cell
infect
moi
vsvgfp
moi
ndvgfp
moi
hsvgfp
moi
cell
infect
vsvgfp
moi
hsvgfp
moi
virus
titrat
vsvgfp
supernat
group
collect
hpi
serial
dilut
independ
vero
cell
cultur
plate
cell
confluenc
approxim
cell
infect
dilut
follow
h
incub
inoculum
remov
replac
agar
g
ml
dw
plate
incub
anoth
h
examin
plaqu
format
magnif
viral
titer
calcul
use
number
plaqueform
unit
dilut
factor
case
hsvgfp
titrat
instead
cell
supernat
infect
cell
group
harvest
hpi
subject
five
cycl
freez
thaw
room
temperatur
cell
resuspend
phosphatebuff
salin
pb
serial
dilut
use
infect
vero
cell
proinflammatori
cytokin
induc
effect
epimedium
koreanum
nakai
vitro
examin
use
commerci
elisa
kit
case
cell
murin
interleukin
il
bd
bioscienc
usa
pbl
interferon
sourc
usa
measur
previous
describ
briefli
cell
cultur
tissu
cultur
tc
plate
cellswel
h
cell
treat
unitsml
recombin
murin
sigmaaldrich
vv
epimedium
koreanum
nakai
dmem
contain
fb
medium
alon
incub
supernat
harvest
hpt
clarifi
centrifug
g
min
dispens
murin
elisa
plate
murin
captur
antibodyco
elisa
plate
case
cell
cell
count
cellswel
recombin
human
sigmaaldrich
use
posit
control
clarifi
supernat
dispens
commerci
human
tfb
inc
tokyo
japan
human
invitrogen
carlsbad
california
usa
elisa
plate
murin
human
human
elisa
perform
duplic
murin
elisa
perform
triplic
cell
grown
sixwel
tissu
cultur
tc
plate
cellswel
incub
cell
treat
dmem
fb
alon
neg
control
dmem
unitsml
recombin
murinehuman
dmem
epimedium
koreanum
nakai
cell
harvest
hpt
total
rna
cell
isol
use
rneasi
mini
kit
qiagen
seoul
korea
cdna
synthesi
perform
use
revers
transcriptas
toyobo
japan
differ
level
cdna
quantifi
realtim
polymeras
chain
reaction
pcr
use
quantitect
sybr
green
pcr
kit
qiagen
seoul
korea
thermal
block
bioneer
korea
pcr
primer
list
tabl
tabl
cell
cultur
sixwel
tissu
cultur
tc
plate
cellswel
incub
hour
cell
treat
dmem
fb
alon
neg
control
dmem
ngml
lp
posit
control
dmem
epimedium
koreanum
nakai
cell
harvest
hpt
cell
pellet
wash
phosphatebuff
salin
pb
subject
immunoblot
analysi
briefli
cell
pellet
lyse
radioimmunoprecipit
assay
ripa
lysi
buffer
mm
trishcl
ph
mm
nacl
sodium
deoxychol
igep
mm
naf
mm
ugml
aprotinin
leupeptin
sampl
separ
sdspage
transfer
onto
pvdf
membran
biorad
buffer
contain
mm
tri
mm
glycin
methanol
h
membran
block
h
trisbuff
salin
contain
tween
bovin
serum
albumin
probe
target
protein
antibodi
fbstbst
incub
perform
overnight
abcam
ser
cell
signal
cell
signal
cell
signal
cell
signal
cell
signal
cell
signal
cell
signal
cell
signal
cell
signal
antierk
cell
signal
antiphosphoerk
cell
signal
antibactin
santa
cruz
sc
antibodi
three
wash
trisbuff
salin
contain
tween
membran
incub
horseradish
peroxidaseconjug
secondari
antibodi
hour
room
temperatur
three
wash
pbst
hrp
reaction
visual
enhanc
chemiluminesc
detect
system
eclg
healthcar
use
mini
lumino
imag
analyz
fiftytwo
femal
fiveweekold
balbc
mice
divid
four
experiment
set
two
group
per
set
four
set
one
two
group
mice
six
lung
viru
titrat
day
postinfect
dpi
remain
three
set
two
group
contain
five
mice
mice
oral
administ
mgml
epimedium
koreanum
nakai
total
volum
per
head
day
infect
mice
control
group
oral
administ
pb
mice
intranas
infect
five
time
mous
lethal
dose
pb
per
mous
treatment
challeng
experi
conduct
approv
facil
bodi
weight
surviv
record
dpi
mice
show
bodi
weight
loss
consid
reach
experiment
end
point
human
kill
dpi
three
mice
two
group
set
randomli
sacrif
measur
lung
viru
titer
anim
studi
conduct
appropri
condit
approv
institut
anim
care
use
committe
biolead
corpor
daejeon
south
korea
protocol
number
accord
institut
nation
intern
law
laboratori
anim
experiment
lung
tissu
euthan
mice
collect
asept
viru
titer
determin
tissu
cultur
infecti
dose
describ
previous
briefli
lung
tissu
homogen
ml
pb
contain
antibiot
penicillin
streptomycin
antimycot
fungizon
compound
gibco
grand
island
ny
usa
mechan
homogen
lung
sampl
centrifug
min
g
remov
cellular
debri
storag
madindarbi
canin
kidney
mdck
cell
confluent
grown
microtit
plate
infect
serial
dilut
dmem
contain
fb
lung
homogen
quadrupl
incub
humid
atmospher
hour
absorpt
media
remov
overlay
medium
contain
chloromethyl
keton
tpck
trypsin
thermo
fisher
scientif
rockford
usa
ad
infect
cell
incub
h
viral
cytopath
effect
cpe
observ
daili
titer
determin
hemagglutin
assay
ha
test
indic
follow
fifti
microlit
chicken
red
blood
cell
rbc
ad
cell
cultur
supernat
incub
room
temperatur
min
well
contain
ha
score
posit
viru
titer
calcul
reed
muench
method
express
lung
tissu
quercetin
kindli
provid
dr
jin
yeul
herbal
medicin
improv
research
center
korea
institut
orient
medicin
daejeon
republ
korea
main
compon
profil
water
extract
epimedium
koreanum
nakai
analyz
use
highperform
liquid
chromatographi
hplc
quercetin
success
purifi
test
antiinfluenza
effect
quercetin
upon
pretreat
compound
quercetin
treat
concentr
h
infect
moi
gfp
express
observ
h
post
infect
hpi
magnif
mous
interferon
ifn
treat
posit
control
unitsml
viru
titrat
secret
cytokin
quercetin
cell
determin
method
describ
data
present
mean
standard
deviat
repres
least
three
independ
experi
differ
group
analyz
analysi
varianc
anova
mean
compar
student
ttest
pvalu
less
regard
signific
result
percent
initi
bodi
weight
also
compar
use
student
test
comparison
surviv
done
logrank
test
use
graphpad
prism
version
author
violat
biodivers
right
handl
prepar
epimedium
koreanum
nakai
throughout
entir
experiment
period
defin
extract
concentr
reduct
viru
titr
observ
wherea
extract
concentr
result
cell
viabil
consid
determin
valu
epimedium
koreanum
nakai
diverg
virus
vitro
develop
modifi
gfp
assay
use
cell
line
reason
use
gfptag
virus
reduct
gfp
express
consid
equival
reduct
viru
titr
shown
tabl
epimedium
koreanum
nakai
inhibit
replic
moi
vsvgfp
moi
ndvgfp
moi
hsvgfp
moi
valu
respect
moreov
extract
inhibit
replic
vsvgfp
moi
hsvgfp
moi
valu
cell
tabl
consid
valu
select
optimum
dosag
extract
vitro
antivir
assay
base
effect
conveni
experi
cytotox
epimedium
koreanum
nakai
assess
base
cell
viabil
test
follow
treatment
variou
concentr
epimedium
koreanum
nakai
valu
cell
respect
tabl
select
index
epimedium
koreanum
nakai
si
vsv
ndv
hsv
cell
respect
vsv
hsv
cell
respect
suggest
extract
could
broadli
use
prophylact
therapeut
agent
evalu
vitro
antivir
activ
epimedium
koreanum
nakai
check
viral
replic
diverg
gfpexpress
virus
includ
rna
dna
virus
cell
viral
replic
monitor
gfpexpress
level
upon
treatment
cytotoxicfre
data
shown
extract
total
aqueou
extract
epimedium
koreanum
nakaitr
cell
vv
exhibit
mark
reduct
gfp
express
wherea
untreat
group
high
level
gfp
express
vsv
figur
figur
ndv
figur
hsv
figur
quantit
extracttr
cell
show
signific
reduct
gfp
express
compar
untreat
group
data
shown
result
correl
viral
titer
vsvgfp
cell
supernat
viral
titer
hsvgfp
infect
cell
epimedium
koreanum
nakai
treatment
reduc
viral
titer
nearli
vsvgfp
hsvgfp
hpi
respect
figur
importantli
epimedium
koreanum
nakaitr
cell
display
signific
reduct
cell
death
follow
infect
test
virus
compar
untreat
cell
figur
case
ndv
measur
mrna
express
ndv
gene
via
rtpcr
estim
replic
figur
right
panel
ndvgfp
expect
express
matrix
gene
mrna
extracttr
cell
decreas
timedepend
manner
compar
untreat
group
hpi
result
clearli
show
evid
total
aqueou
extract
epimedium
koreanum
nakai
abl
reduc
replic
vsv
ndv
hsv
virus
cell
determin
antivir
activ
epimedium
koreanum
nakai
human
embryon
kidney
cell
similarli
antivir
activ
observ
gfptag
vsv
hsv
virus
upon
pretreat
extract
shown
figur
b
extracttr
cell
exhibit
markedli
reduc
gfp
express
viru
titer
compar
untreat
group
present
high
level
gfp
express
viru
replic
moreov
extracttr
cell
show
signific
reduct
cell
death
follow
infect
test
virus
compar
untreat
cell
result
clearli
indic
total
aqueou
extract
epimedium
koreanum
nakai
also
reduc
replic
rna
dna
virus
epitheli
cell
elucid
possibl
mechan
antivir
activ
epimedium
koreanum
nakai
measur
level
proinflammatori
cytokin
secret
extracttr
supernat
cell
figur
shown
figur
epimedium
koreanum
nakai
induc
high
level
secret
hpt
hpt
compar
cell
concentrationdepend
manner
also
secret
significantli
higher
level
although
secret
level
high
level
obtain
cell
moreov
epimedium
koreanum
nakai
induc
secret
cell
figur
secret
amount
significantli
high
line
human
posit
control
result
suggest
epimedium
koreanum
nakai
stimul
immun
cell
epitheli
cell
induc
secret
ifn
proinflammatori
cytokin
may
mediat
antivir
state
cell
antivir
respons
epimedium
koreanum
nakai
may
relat
innat
immun
respons
express
cytokin
correl
observ
ifninduc
signal
pathway
examin
phosphoryl
interferon
relat
signal
molecul
phosphoryl
relat
nfkb
activ
immunoblot
analys
perform
use
whole
cell
lysat
extracttr
cell
shown
figur
epimedium
koreanum
nakai
significantli
upregul
phosphoryl
erk
key
signal
molecul
belong
type
interferon
ifn
pathway
phosphoryl
key
indic
interferon
signal
transduct
upon
viru
infect
phosphoryl
transloc
nucleu
initi
transcript
type
interferon
ifn
consequ
produc
type
interferon
ifn
bind
jakstat
pathway
lead
phosphoryl
transcript
activ
interferonstimul
gene
isg
activ
isg
involv
control
viral
infect
result
clearli
demonstr
treatment
epimedium
koreanum
nakai
extract
induc
potent
phosphoryl
hpt
effect
markedli
increas
time
furthermor
increas
phosphoryl
indic
activ
function
isg
addit
activ
type
interferon
ifn
extracttr
cell
abl
elicit
obviou
activ
lead
strong
secret
proinflammatori
cytokin
phosphoryl
molecul
induc
extract
compar
obtain
lp
treatment
known
potent
stimul
evalu
induct
differ
antivir
interferonstimulatori
gene
transcript
level
respons
epimedium
koreanum
nakai
treatment
cell
cell
treat
epimedium
koreanum
nakai
concentr
confirm
realtim
pcr
mrna
express
level
variou
antivir
interferon
stimulatori
gene
upregul
level
similar
found
posit
control
figur
initi
determin
transcript
level
variou
antivir
gene
epimedium
koreanum
nakaitr
cell
hpt
hpt
realtim
pcr
assay
perform
monitor
timedepend
mrna
chang
normal
gapdh
extracttr
cell
display
sevenfold
increas
level
mrna
hpt
ninefold
induct
level
hpt
compar
untreat
cell
respect
figur
therefor
perform
pcr
assay
gene
interest
hpt
use
specif
primer
tabl
tabl
cell
found
transcript
level
variou
antivir
gene
upregul
epimedium
koreanum
nakai
hpt
includ
pml
level
higher
respect
control
cell
moreov
transcript
level
observ
upregul
respect
addit
elev
level
extract
induc
transcript
interferonstimulatori
gene
isg
respect
hpt
cell
observ
elev
transcript
pattern
antivir
gene
similar
pattern
posit
control
furthermor
similar
transcript
activ
pattern
observ
extract
treat
cell
interestingli
highest
fold
induct
cellular
transcript
level
observ
hpt
primer
transcript
level
extracttr
cell
upregul
respect
importantli
highest
transcript
induct
level
observ
respect
transcript
pattern
similar
pattern
human
posit
control
overal
result
suggest
epimedium
koreanum
nakai
capac
upregul
transcript
level
interferonstimul
gene
isg
variou
antivir
gene
molecularlevel
activ
may
direct
relationship
extract
antivir
abil
observ
cell
confirm
prophylact
effect
epimedium
koreanum
nakai
divers
influenza
viral
infect
oral
inocul
extract
group
balbc
mice
infect
time
mous
lethal
dose
aaquat
influenza
subtyp
mice
oral
treat
epimedium
koreanum
nakai
per
head
total
volum
infect
lethal
dose
influenza
subtyp
minimum
effect
dose
per
head
chosen
base
previou
vivo
experiment
experi
variou
herbal
extract
data
shown
challeng
untreat
pb
group
observ
sever
ill
bodi
weight
found
decreas
progress
moreov
control
group
succumb
death
day
post
infect
dpi
regardless
viru
use
infect
contrast
epimedium
koreanum
nakaitr
mice
show
bodi
weight
loss
dpi
begun
recov
lost
weight
dpi
return
normal
state
dpi
figur
furthermor
group
oral
inocul
herbal
extract
preinfect
similar
protect
level
influenza
subtyp
test
figur
abil
epimedium
koreanum
nakai
inhibit
viral
replic
lung
tissu
infect
mice
evalu
experiment
set
three
mice
group
sacrif
lung
collect
day
postinfect
viral
titrat
overal
oral
inocul
epimedium
koreanum
nakai
reduc
viral
titer
lung
infect
mice
extracttr
group
compar
untreat
control
lung
viral
titer
log
log
dpi
dpi
respect
interestingli
extracttr
group
significantli
reduc
viral
titer
log
log
dpi
dpi
respect
figur
taken
togeth
result
indic
epimedium
koreanum
nakai
induc
antivir
state
suffici
strong
inhibit
viral
replic
promot
surviv
mice
lethal
infect
divers
influenza
virus
epimedium
koreanum
nakai
natur
product
contain
mani
effect
compon
detail
understand
main
compon
profil
water
extract
epimedium
koreanum
nakai
highperform
liquid
chromatographi
hplc
system
employ
among
marker
compound
epimedium
koreanum
nakai
quercetin
icariin
repres
identifi
nm
base
comparison
standard
compound
base
test
antiinfluenza
effect
quercetin
upon
pretreat
compound
minimum
effect
dose
chosen
base
preliminari
experi
efficaci
quercetin
data
shown
interestingli
treatment
quercetin
markedli
inhibit
viru
replic
figur
quercetintr
group
display
reduc
gfp
express
compar
untreat
group
high
level
gfp
express
observ
gfp
data
correl
viral
titer
quercetin
treatment
reduc
viral
titer
nearli
hpi
figur
furthermor
treatment
quercetin
mark
increas
cytokin
secret
cell
figur
data
strongli
suggest
quercetin
major
constitu
epimedium
koreanum
nakai
might
abl
induc
antivir
state
cell
subsequ
inhibit
viru
replic
concern
relat
side
effect
higher
cost
lack
efficaci
convent
medicin
use
natur
product
altern
convent
treatment
heal
treatment
variou
diseas
increas
last
decad
among
natur
product
medicin
plant
serv
viabl
altern
safer
choic
case
effect
treatment
moreov
use
plant
medicin
date
earliest
year
man
evolut
therefor
pose
less
safetyrel
concern
larger
number
plant
isol
constitu
shown
benefici
prevent
therapeut
effect
includ
antioxid
antiinflammatori
anticanc
antibacteri
immunemodulatori
properti
moreov
substitut
chemosynthesi
drug
vaccin
medicin
plant
show
potenti
wide
rang
virus
vaccinia
vesicular
stomati
viru
sendai
viru
etc
particular
antiinfluenza
viru
effect
sever
herbal
extract
report
among
promis
medicin
plant
epimedium
koreanum
nakai
herb
rich
histor
background
mainli
found
wild
mainland
china
korea
studi
demonstr
epimedium
koreanum
nakai
contain
broad
spectrum
antivir
activ
vitro
diverg
subtyp
influenza
viru
balbc
mice
cytotox
antivir
reagent
epimedium
koreanum
nakai
use
human
consumpt
long
time
side
effect
dose
rare
report
importantli
epimedium
koreanum
nakai
signific
cytotox
effect
test
cell
line
moreov
cell
cytotox
concentr
epimedium
koreanum
nakai
sever
magnitud
higher
effect
concentr
select
index
si
epimedium
koreanum
nakai
variou
virus
indic
higher
safeti
margin
extract
therapeut
andor
prophylact
purpos
first
found
total
aqueou
extract
epimedium
koreanum
nakai
inhibit
replic
influenza
figur
vsv
figur
figur
ndv
figur
hsv
figur
figur
virus
immun
cell
epitheli
cell
moreov
oral
administr
epimedium
koreanum
nakai
increas
surviv
rate
mice
subject
lethal
challeng
differ
influenza
viru
subtyp
includ
figur
although
epimedium
koreanum
nakaiinocul
mice
initi
display
littl
weight
reduct
major
lose
bodi
weight
contrast
mice
control
group
display
loss
within
dpi
human
kill
influenza
viru
caus
rapid
reduct
bodi
weight
infect
mice
therefor
bodi
weight
loss
consid
human
end
point
sacrif
influenza
virusinfect
mice
result
suggest
epimedium
koreanum
nakai
suffici
strong
inhibit
viral
replic
promot
surviv
mice
lethal
infect
divers
influenza
virus
viral
infect
host
initi
recogn
infect
rapidli
evok
induct
type
interferon
proinflammatori
cytokin
gener
antivir
innat
immun
respons
induct
antivir
state
earli
point
viru
infect
critic
control
spread
pathogenesi
virus
likewis
hypothes
epimedium
koreanum
nakai
induc
antivir
state
via
induct
type
interferon
proinflammatori
cytokin
determin
induct
antivir
ifnstimul
gene
isg
figur
secret
figur
epimedium
koreanum
nakai
vitro
fact
interferon
proinflammatori
cytokin
product
benefici
harm
effect
depend
amount
time
durat
cytokin
releas
instanc
pathogen
influenza
viru
infect
robust
cytokin
product
cytokin
storm
excess
inflammatori
infiltr
virusinduc
tissu
destruct
contribut
morbid
mortal
howev
induc
antivir
state
tight
regul
import
defens
mechan
viru
infect
interestingli
upon
challeng
virus
notabl
pattern
cytokin
regul
secret
observ
epimedium
koreanum
nakaitr
cell
correl
observ
found
cell
viabil
assay
studi
figur
figur
detail
understand
epimedium
koreanum
nakai
activ
antivir
signal
examin
effect
epimedium
koreanum
nakai
phosphoryl
erk
key
signal
molecul
present
type
ifn
signal
pathway
upon
stimul
prr
pattern
recognit
receptor
unknown
receptor
host
cell
foreign
materi
contain
pathogen
downstream
signal
transduct
activ
includ
activ
adaptor
signal
molecul
transcript
factor
initi
induct
type
interferon
proinflammatori
cytokin
upregul
antivir
statu
host
cell
studi
found
epimedium
koreanum
nakai
treatment
induc
phosphoryl
timedepend
manner
provid
evid
downstream
signal
transduct
type
ifn
signal
pathway
figur
addit
activ
perk
lead
strong
secret
proinflammatori
cytokin
could
also
observ
phosphoryl
lead
rapid
product
type
ifn
variou
inflammatori
cytokin
play
pivot
role
stimul
antivir
state
subsequ
clearanc
virus
actual
endotoxin
lp
known
immunomodul
often
contamin
biolog
prepar
thu
one
princip
concern
field
macrophagestimul
properti
herbal
extract
may
due
contamin
bacteri
endotoxin
lp
lipid
aassoci
protein
therefor
epimedium
koreanum
nakai
test
endotoxin
contamin
use
limulu
amebocyt
lysat
lal
assay
assay
found
contamin
trace
amount
endotoxin
figur
cell
mous
macrophag
versatil
immun
system
cell
play
indispens
role
innat
adapt
immun
respons
exhibit
variou
immun
respons
pathogen
challeng
phagocytosi
cytokin
secret
antigen
present
adher
wide
rang
function
macrophag
extens
studi
signific
role
immun
system
particularli
antivir
respons
moreov
immunestimul
effect
differ
substanc
well
establish
murin
macrophag
cell
previou
studi
elucid
capac
murin
macrophag
achiev
antivir
state
upon
success
stimul
consequ
decid
use
murin
macrophag
evalu
antivir
effect
watersolubl
herbal
extract
epimedium
koreanum
nakai
diverg
virus
contrast
human
embryon
kidney
cell
epitheli
cell
less
known
relationship
immun
system
known
cell
less
promin
pattern
recognit
receptor
prr
especi
tolllik
receptor
tlr
suggest
activ
cell
activ
compound
must
penetr
cell
membran
activ
receptor
present
cytoplasm
therefor
clear
aqueou
extract
epimedium
koreanum
nakai
contain
compon
stimul
cell
surfac
prr
cytoplasm
prr
therefor
epimedium
koreanum
nakai
abil
modul
cell
benefici
manner
indic
broad
antivir
potenti
report
epimedium
koreanum
nakai
contain
variou
activ
compon
includ
flavonoid
flavonol
glycosid
alkaloid
polysaccharid
microel
flavonoid
epimedium
koreanum
nakai
mainli
contain
icariin
qercetin
icarisid
ii
epimedin
epimedosid
hyperosid
chlorogen
acid
previou
studi
identifi
main
compon
epimedium
koreanum
nakai
quercetin
icariin
use
hplc
quercetin
major
activ
compon
epimedium
koreanum
nakai
shown
inhibit
porcin
epidem
diarrhea
viru
base
lead
test
quercetin
antivir
activ
immunemodulatori
properti
quercetin
display
strike
antivir
properti
induc
cytokin
secret
figur
confirm
import
observ
biolog
properti
therefor
observ
antivir
effect
epimedium
koreanum
nakai
must
due
presenc
quercetin
activ
compound
epimedium
koreanum
nakai
relationship
mechan
antivir
effect
activ
compound
contain
quercetin
must
studi
present
studi
notic
treatment
total
aqueou
extract
epimedium
koreanum
nakai
display
strike
antivir
effect
vitro
vivo
anim
model
underli
mechan
valuabl
compon
epimedium
koreanum
nakai
includ
quercetin
could
induc
secret
type
ifn
proinflammatori
cytokin
stimul
antivir
state
host
cell
promis
prophylact
agent
inhibit
viral
infect
activ
howev
optimum
dosag
epimedium
koreanum
nakai
practic
applic
longev
effect
within
host
examin
obtain
better
protect
viral
infect
present
studi
strongli
suggest
total
aqueou
extract
epimedium
koreanum
nakai
antivir
effect
vsvgfp
ndvgfp
hsvgfp
vitro
diverg
influenza
subtyp
vivo
mous
model
moreov
studi
indic
extract
epimedium
koreanum
nakai
contain
quercetin
activ
compon
induc
secret
type
ifn
proinflammatori
cytokin
subsequ
stimul
antivir
state
host
cell
possibl
mechan
thu
use
epimedium
koreanum
nakai
oral
antivir
agent
potenti
effect
herbal
remedi
prophylaxi
therapeut
applic
human
livestock
